We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combination Rapid Diagnostic Tests Evaluated for Malaria in Pregnancy

By LabMedica International staff writers
Posted on 10 Nov 2015
Print article
Image: The CareStart Malaria pLDH/HRP2 combo rapid diagnostic test (Photo courtesy of Access Bio Inc.).
Image: The CareStart Malaria pLDH/HRP2 combo rapid diagnostic test (Photo courtesy of Access Bio Inc.).
Early detection and effective management of asymptomatic and symptomatic malaria is essential to reduce the burden of malaria in pregnancy.

The potential risk of Plasmodium falciparum or P. vivax malaria and the corresponding risk of malaria associated maternal anemia and low birth weight due to pre-term delivery or intra-uterine growth retardation needs to be urgently addressed.

An international team of scientists led by those at the Liverpool School of Tropical Medicine (UK) enrolled pregnant women of any gravidity aged between 15 and 49 years who attended clinics for routine antenatal care between March and July 2012. A finger prick blood sample was taken to simultaneously test the four rapid diagnostic tests (RDTs), malaria microscopy and dried blood spots for polymerase chain reaction (PCR).

Thick and thin smears were made on the same slide and stained with 5 % Giemsa. A slide was declared negative if parasites were absent after examining 200 high power fields. Parasite density was quantified against 300 leukocytes on an assumed leukocyte count of 8,000/µL of blood. The four HRP-2/pLDH RDTs included Parascreen Rapid Test Pan/Pf (Zephyr Biomedical System; Goa, India); SD Bioline Malaria Ag Pf/Pan (Standard Diagnostic Inc.; Suwon City, Republic of Korea); CareStart Malaria pLDH/HRP2 combo (Access Bio Inc.; Somerset, NJ, USA); the two RDTs used in the malaria control program in Indonesia at the time of the study, and First Response Malaria pLDH/HRP-2 combo (Premier Medical Corporation Ltd.; Kachigam, India). Nested PCR was performed on all samples to detect malaria parasites and for speciation.

Overall 950 women were recruited and 98.7% were asymptomatic. The prevalence of malaria was 3.0% to 3.4% by RDTs, and 3.6% by field microscopy, 5.0% by expert microscopy and 6.6% by PCR, The geometric-mean parasite density was low, P. falciparum = 418 parasites/µL, and P. vivax = 147/µL. Compared with PCR, the overall sensitivity of the RDTs and field microscopy to detect any species was 24.6% to 31.1%; specificities were greater than 98.4 %. Relative to PCR, the First-Response RDT had the best diagnostic accuracy for any species with the sensitivity = 31.1 %, and specificity = 98.9 %.

The authors concluded that the diagnostic accuracy to detect malaria among mostly asymptomatic pregnant women and perceived ease of use was slightly better with First-Response, but overall, differences between the four RDTs were small and performance comparable to field microscopy. Combination RDTs are a suitable alternative to field microscopy to screen for malaria in pregnancy in rural Indonesia. The clinical relevance of low density malaria infections detected by PCR, but undetected by RDTs or microscopy needs to be determined. The study was published on October 29, 2015, in the Malaria Journal.

Related Links:

Liverpool School of Tropical Medicine 
Zephyr Biomedical System 
Access Bio Inc. 



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Immunoassays and Calibrators
QMS Tacrolimus Immunoassays

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.